Status:
UNKNOWN
Predicitve Use of Spot Urine Protein/Creatinine Ratios in Preeclampsia
Lead Sponsor:
MemorialCare
Collaborating Sponsors:
University of California, Irvine
Conditions:
Preeclampsia
Eligibility:
FEMALE
18+ years
Brief Summary
The investigators intend to perform a large prospective study looking at the predictability of the random urine protein-to-creatinine ratio compared to the gold standard 24-hour urine protein collecti...
Detailed Description
Preeclampsia affects approximately 5-8% of pregnancies in the United States with approximately 10% occurring before 34 weeks gestation. The diagnosis of preeclampsia is determined by the presence of h...
Eligibility Criteria
Inclusion
- Pregnant women over the age of 18 between 24-42 weeks who are being evaluated for preeclampsia with a 24 hour urine protein
Exclusion
- Patients with pre-existing proteinuria (\>300mg)
- Renal disease
- Evidence of a current or recent (within two weeks of admission) urinary tract infection
Key Trial Info
Start Date :
March 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
117 Patients enrolled
Trial Details
Trial ID
NCT00870428
Start Date
March 1 2009
Last Update
March 27 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Long Beach Memorial Womens Pavillion
Long Beach, California, United States, 90806